🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

23 recruiting trials

for MSK Conditions

Safety and Tolerability of EO2002 NCT05587205Phase 11 site📍 Mexico City Asociación para Evitar la Ceguera en México · Tests: EO2002, Sham injection Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) NCT06891443Phase 318 sites📍 San Francisco📍 Miami📍 Iowa City Laboratoires Thea · Tests: sepofarsen, Placebo IVT Feasibility and Acceptability of an Evidence-Informed Virtual Intervention to Reduce Perceptions of Injustice Following Work Injury NCT07072702NA1 site📍 Montreal McGill University · Tests: Managing Post-Injury Challenges (MPIC) A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema NCT06962839Phase 297 sites📍 Phoenix📍 Arcadia📍 Huntington Beach Boehringer Ingelheim · Tests: BI 1815368, Placebo Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research NCT07623668Phase 34 sites📍 Livonia📍 Charleston📍 Dallas Oculis · Tests: Privosegtor, Methylprednisolone, Placebo Sarcopenia in Colorectal Cancer Patients, Intervention Study NCT05491434NA1 site📍 L'Hospitalet de Llobregat Hospital Universitari de Bellvitge · Tests: Protein supplement A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome NCT07710196Phase 31 site📍 Dallas Nacuity Pharmaceuticals, Inc. · Tests: Placebo, NPI-001 A Study of NTRX-07 in Participants With Alzheimer's Disease NCT07058688Phase 26 sites📍 Brno📍 Prague📍 Budapest NeuroTherapia, Inc. · Tests: NTRX-07, Placebo Virtual Reality and Standard Care vs. Standard Care Alone for Acute MSK Pain in Geriatric ED Patients NCT06685107NA1 site📍 Brooklyn Antonios Likourezos · Tests: Standard of Care Analgesia, Standard of Care Analgesia + Virtual Reality A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery NCT07694375Phase 28 sites📍 Deakin📍 Baulkham Hills📍 Blacktown Caravel Oculus Pty Ltd · Tests: Ophthalmic solution (matching formulation without ascorbic acid), Ascorbic acid ophthalmic solution 5% Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) NCT07482176Phase 379 sites📍 Mesa📍 Phoenix📍 Phoenix Adverum Biotechnologies, Inc. · Tests: Ixo-vec, Aflibercept OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity NCT07140783Phase 320 sites📍 Chandler📍 Phoenix📍 Scottsdale Opus Genetics, Inc · Tests: 0.75% Phentolamine Ophthalmic Solution, Placebo Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis NCT06859164Phase 21 site📍 Chicago University of Chicago · Tests: Genicular Artery Embolization, Lipiodol, Simple angiogram Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy NCT07531927NA5 sites📍 Hamburg📍 München📍 Stuttgart Okuvision GmbH · Tests: Transcorneal electrical stimulation (TES) with the OkuStim 2 System, Transcorneal electrical stimulation (TES) with the… A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD NCT06659549Phase 224 sites📍 Beverly Hills📍 Walnut Creek📍 Hagerstown Galimedix Therapeutics Inc · Tests: GAL-101, Placebo FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers NCT07638371Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: MSK-TCR5 A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) NCT07496567Phase 2, Phase 371 sites📍 Gilbert📍 Encino📍 Mountain View EyeBiotech Ltd. · Tests: Tiespectus, Aflibercept Precision Based Primary Care for Patients With Musculoskeletal Disorders NCT07603674n/a1 site📍 Stockholm Karolinska Institutet · Tests: No intervention Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients NCT06917950Phase 1, Phase 21 site📍 Al Mansurah Mansoura University · Tests: Roxadustat, Conventional Anemia Management A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) NCT07440225Phase 2, Phase 3132 sites📍 Scottsdale📍 Fayetteville📍 Springdale EyeBiotech Ltd. · Tests: Tiespectus, Aflibercept Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy NCT06576986NA1 site📍 Belo Horizonte Federal University of Minas Gerais · Tests: Symbiotic, Maltodextrin A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy NCT06321302Phase 290 sites📍 Phoenix📍 Bakersfield📍 Beverly Hills Boehringer Ingelheim · Tests: BI 764524, Sham comparator to BI 764524, Aflibercept (Eylea®) - US only Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction NCT07729137Phase 210 sites📍 Torrance📍 Largo📍 Atlanta Emmecell · Tests: 150K cells, 500K cells, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy